(Q35043204)

6 August 2017

title

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting (English)

1 reference

6 August 2017

1 reference

2

Domenico Motola

1 reference

6 August 2017

Carlo Piccinni

1

0 references

Elisabetta Poluzzi

object named as

Elisabetta Poluzzi

series ordinal

4

0 references

Giulio Marchesini

object named as

Giulio Marchesini

series ordinal

3

0 references

language of work or name

English

0 references

publication date

22 April 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

34

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1369-1371

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

6 August 2017

copyright license

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Changes in glitazone use among office-based physicians in the U.S., 2003-2009.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Glucocorticoid therapy and risk of bladder cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Perspectives on the use of data mining in pharmaco-vigilance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114317

'Extreme duplication' in the US FDA Adverse Events Reporting System database

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21515844

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC10-2412

1 reference

6 August 2017

1 reference

6 August 2017

1 reference